Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - GROSS PROFIT
Gross Profit PRPH - ProPhase Labs, Inc.
16.2 M
LAST VALUE
-29.65%
2 YEAR CAGR
27.71%
5 YEAR CAGR
-0.26%
10 YEAR CAGR